FATE THERAPEUTICS
Fate Therapeutics is using the fundamental biological mechanisms that guide cell fate to develop stem cell therapeutics. The company has brought together the foremost scientists from the nation's research hotbeds (Boston, San Francisco, San Diego, and Seattle) who have demonstrated the potential to create and modulate stem cells to restore health. The backstory is that while others were working towards therapies based on transplanting stem cell-derived cells into patients, Randall Moon (HHMI ... and the University of Washington) and Alex Rives (Arch Venture Capitol) envisioned a different approach to develop regenerative therapies. The concept, based on data from hematopoietic progenitor cells, was that one could modulate the properties of stem cells in vivo using small molecules or biologics. They presented this idea to Arch Venture Capitol in Seattle, which launched the company, soon to be joined by other investors.
FATE THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2007-01-01
Address:
La Jolla, California, United States
Country:
United States
Website Url:
http://www.fatetherapeutics.com
Total Employee:
101+
Status:
Closed
Contact:
8588751802
Email Addresses:
[email protected]
Total Funding:
1.21 B USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics WordPress Google Universal Analytics Sitelinks Search Box IPv6 Yoast WordPress SEO Plugin Google Maps
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2010-04-08 | Verio Therapeutics | Verio Therapeutics acquired by Fate Therapeutics | N/A |
Investors List
California Institute for Regenerative Medicine
California Institute for Regenerative Medicine investment in Grant - Fate Therapeutics
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Fate Therapeutics
OVP Venture Partners
OVP Venture Partners investment in Series B - Fate Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Fate Therapeutics
Venrock
Venrock investment in Series B - Fate Therapeutics
Polaris Partners
Polaris Partners investment in Series B - Fate Therapeutics
Astellas Venture Management
Astellas Venture Management investment in Series B - Fate Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Fate Therapeutics
Venrock
Venrock investment in Series B - Fate Therapeutics
Sanofi Ventures
Sanofi Ventures investment in Series B - Fate Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-30 | Fate Therapeutics Appoints Brian T. Powl as Chief Commercial Officer |
| 2020-08-19 | Fate Therapeutics Taps Celgene’s Dulac as Its Chief Financial Officer |
Official Site Inspections
http://www.fatetherapeutics.com Semrush global rank: 2.24 M Semrush visits lastest month: 8.54 K
- Host name: mlchristyphoto.com
- IP address: 208.113.235.136
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
